Regulations, Generics, and Disruptive Technologies in Ophthalmology: What Every Scientist Needs to Know
J Ocul Pharmacol Ther
.
2021 Apr;37(3):141.
doi: 10.1089/jop.2021.29078.
Epub 2021 Mar 17.
Authors
Cheryl L Rowe-Rendleman
1
,
Randolph D Glickman
2
Affiliations
1
Omar Consulting Group, LLC, Durham, North Carolina, USA.
2
Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
PMID:
33733867
DOI:
10.1089/jop.2021.29078
No abstract available
MeSH terms
Disruptive Technology*
Drugs, Generic / therapeutic use*
Eye Diseases / drug therapy*
Humans
Ophthalmology
Physicians
Substances
Drugs, Generic